References
- Aarli J. A. Drug induced IgA deficiency in epileptic patients. Archives of Neurology 1976; 33: 296
- Basaran N., Hincal F., Kansu E., Ciger A. Humoral and cellular immune parameters in untreated and phenytoin- or carbamazepine-treated epileptic patients. International Journal of Immunopharmacology 1994; 6: 1071–7
- Bassanini B., Baez A., Sotelo J. Immunoglobulins in epilepsy. Journal of Neurological Science 1982; 56: 275–81
- Coenen A. M. L., Van Luijelaar E. L. J. M. The WAG/Rij model for generalized absence seizures. Advances in Epileptology, J. Manelis, et al. Raven Press, New York 1989; Vol. 17: 78–83
- Dalby N. O., Rondouin G., Lerner-Natoli M. Increase in GAP-43 and GFAP immunoreactivity in the rat hippocampus subsequent to perforant path kindling. J. Neurosci. Res. 1995; 41: 613–9
- Duse M., Tiberti S., Plebani A., Avanzini M. A., Gardenghi M., Menegati E., Monafo V., Ugazio A. G. IgG2 deficiency and intractable epilepsy of childhood. Monorg. Allergy 1986; 20: 128–34
- Eeg-Olofsson O., Prchal J. F., Andermann F. Abnormalities of T-lymphocyte subsets in epileptic patients. Acta Neurol. Scand. Aug., 1985; 72(2)140–4
- Gilhus N. E., Aarli J. A. The reversibility of phenytoin-induced IgA deficiency. J. Neurol. 1981; 226: 53
- Hirayama H., Kurimoto T., Wada S., Shoji S., Machida N., Shikuma H., Horibe M. Antiepileptic effects of globulin-N, an intact human immunoglobulin and its tissue-distribution in kindled cats. Int. J. Clin. Pharmacol. Ther. Toxicol. 1986; 24(3)109–22
- Lenti C., Masserini C, Peruzzi C., Guareschi C. A. Effects of carbamazepine and valproate on immunological assessment in young epileptic patients. Ital. J. Neurol. Sci. 1991; 12: 87–91
- Meis S., Biella G., Pape H. C. Interaction between low voltage-activated currents in reticular thalamic neurons in a rat model of absence epilepsy. Eur. J. Neurosci. 1996; 8(10)2090–7
- Palkavits M., Brownstern M. J. Maps and Guide to Microdissection of the Rat Brain. Elsevier Science Publishing Co. Inc. 1988
- Ransom B. R., Orkland R. K. Glial-neuronal interactions in non-synaptic areas of the brain: studies in the optic nerve. Trends Neurosci 1996; 19(8)352–8
- Renkawek K., Renier W. O., de Pont J. J. H. H. M., Vogels O. J. M, Gabreels F. J. M. Neonatal status convulsivus, spongiform encephalopathy, and low activity of Na+ /K+ - ATPase in the brain. Epilepsia 1992; 33(1)58–64
- Riikonen R. Infantile spasms: some new theoretical aspects. Epilepsia 1983; 24(2)159–168
- Seager J., Wilson J., Jamison D. L., Hayward A. R., Soothill J. F. IgA deficiency, epilepsy and phenytoin treatment. Lancet 1975; ii: 632
- Sorell T. C., Forbes I. J., Burnes F. R. Rischbieth RHC. Depression of immunological function in patients treated with phenytoin sodium. Lancet 1971; ii: 1233–5
- Steward O., Kelley M. S., Schaucwecker P. E. Signals that regulate astroglial gene expression: Induction of GFAP mRNA following seizures or injury is blocked by protein synthesis inhibitors. Exp. Neurol. 1997; 148: 100–9
- van-Engelen B. G., Ates N., Drinkenburg W. H. I. M. Immunoglobulin treatment in epilepsy: Antiepileptic and behavioural effects of human polyclonal immunoglobulin in an animal model for generalized epilepsy. Quovenistel 1986 Epilepsy Research in The Netherlands-1991, H. van Duijn, W. F. Rietveld, J. L. Blom. National Epilepsie Fonds, The Netherlands 1994a; 101–2
- van-Engelen B. G., Renier W. O., Weemaes C. M., Strengers P. F., Bernsen P. J., Notermans S. L. High dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study. Eur. J. Pedialr. 1994b; 153(10)762–9
- van-Engelen B. G., van Den Beukel I., Voskuyl R. A., Weemaes C. M., Renier W. O. Can human polyclonal immunoglobulin raise the threshold for convulsions in rats?. Seizure 1996; 5(3)171–4
- Wang X. L., Shen G. X., Sun B., Su N. Studies on lymphocyte subpopu-lations and NK cell activities in epileptic patients. J. Tongji Med. Univ. 1989; 9(1)25–8